| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0006-8993(81)90500-X |
| P698 | PubMed publication ID | 7260586 |
| P2093 | author name string | Landry DW | |
| Flood JF | |||
| Jarvik ME | |||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | long-term memory | Q18601 |
| P304 | page(s) | 177-185 | |
| P577 | publication date | 1981-06-01 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Cholinergic receptor interactions and their effects on long-term memory processing. | |
| P478 | volume | 215 |
| Q41611139 | "Amyloid is not a tombstone"--a summation. The primary role for cerebrovascular and CSF dynamics as factors in Alzheimer's disease (AD): DMSO, fluorocarbon oxygen carriers, thyroid hormonal, and other suggested therapeutic measures |
| Q48737824 | A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease |
| Q37196488 | Alzheimer's disease drugs: an application of the hormetic dose-response model |
| Q47796963 | Anhydroecgonine Methyl Ester (AEME), a Product of Cocaine Pyrolysis, Impairs Spatial Working Memory and Induces Striatal Oxidative Stress in Rats |
| Q48284797 | Animal models of Alzheimer's disease: behavior, pharmacology, transplants. |
| Q34740941 | Applications of hormesis in toxicology, risk assessment and chemotherapeutics |
| Q37206660 | Beneficial effects of nicotine |
| Q52259094 | Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine. |
| Q35155701 | Chemotherapeutics and hormesis |
| Q28286999 | Cholinergic modulation of memory in rats |
| Q52023844 | Cholinergic modulation of neocortical long-term potentiation in the awake, freely moving rat. |
| Q52046676 | Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease. |
| Q46896407 | Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer's disease |
| Q30470065 | Consolidation and long-term retention of an implanted behavioral memory |
| Q43689791 | Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats |
| Q41702520 | Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus murinus). |
| Q46601037 | Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial-arm maze |
| Q52080165 | Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats. |
| Q42258461 | Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents |
| Q44006361 | Facilitation of inhibitory avoidance by hypertonic saline is reversed by a vasopressin and a nicotinic antagonist |
| Q36486980 | Food for thought: honeybee foraging, memory, and acetylcholine |
| Q52248780 | Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics. |
| Q37142421 | Hormesis and medicine |
| Q44693677 | Hormesis: its impact on medicine and health |
| Q42542483 | Long-lasting antiamnesic effect of a novel anticholinesterase inhibitor (MF268). |
| Q48700839 | Long-term suppression in mice of the development of complementary memory storage sites: Effect of a Muscarinic antagonist |
| Q48185494 | Mecamylamine prevents the enhancement of retention induced by lysine vasopressin in mice. |
| Q52208340 | Memory enhancement: supra-additive effect of subcutaneous cholinergic drug combinations in mice. |
| Q52068509 | Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's disease. |
| Q30460201 | Memory modulation |
| Q52080368 | Memory modulation with peripherally acting cholinergic drugs |
| Q52127075 | Modulation of memory by post-training epinephrine: involvement of cholinergic mechanisms. |
| Q30488620 | Motivationally neutral stimulation of the nucleus basalis induces specific behavioral memory |
| Q39766056 | Muscarinic cholinergic agonists: pharmacological and clinical perspectives. |
| Q42718263 | Neuroprotective effects of Rosa damascena extract on learning and memory in a rat model of amyloid-β-induced Alzheimer's disease |
| Q39595749 | Nicotine and smoking: a perspective from animal studies |
| Q34320961 | Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease. |
| Q41392186 | Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats |
| Q45134804 | Quercetin protects against chronic aluminum-induced oxidative stress and ensuing biochemical, cholinergic, and neurobehavioral impairments in rats. |
| Q30457412 | Rapid induction of specific associative behavioral memory by stimulation of the nucleus basalis in the rat. |
| Q38459411 | Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study Group. |
| Q42210723 | Scopolamine amnesia of passive avoidance: a deficit of information acquisition |
| Q42227044 | Scopolamine effects on memory retention in mice: a model of dementia? |
| Q48727475 | Scopolamine-induced impairment in concurrent fixed-interval responding in a radial maze task |
| Q48570838 | Searching for models of Alzheimer's disease: a comparison of four amnestic treatments in two behavioral tasks |
| Q30480689 | Sensory memory consolidation observed: increased specificity of detail over days |
| Q30487255 | Specific auditory memory induced by nucleus basalis stimulation depends on intrinsic acetylcholine |
| Q48703624 | Strain-dependent effects of D2 dopaminergic and muscarinic-cholinergic agonists and antagonists on memory consolidation processes in mice. |
| Q51578054 | Strain-dependent effects of cocaine on memory storage improvement induced by post-training physostigmine. |
| Q48232731 | Strain-dependent involvement of D1 and D2 dopamine receptors in muscarinic cholinergic influences on memory storage |
| Q40454009 | Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model. |
| Q48557554 | The cortical neuropeptide, cortistatin-14, impairs post-training memory processing |
| Q51973543 | The effects of piracetam on morphine-induced amnesia and analgesia: the possible contribution of central opiatergic mechanisms on the antiamnestic effect of piracetam. |
| Q52023567 | The effects of some K(+) channel blockers on scopolamine- or electroconvulsive shock-induced amnesia in mice. |
| Q46511484 | The four-plates test-retest paradigm to discriminate anxiolytic effects |
| Q37426290 | The inverted "u-shaped" dose-effect relationships in learning and memory: modulation of arousal and consolidation |
| Q30457410 | The level of cholinergic nucleus basalis activation controls the specificity of auditory associative memory |
| Q35548436 | The nucleus basalis and memory codes: auditory cortical plasticity and the induction of specific, associative behavioral memory |
| Q38826210 | True alignment of preclinical and clinical research to enhance success in CNS drug development: a review of the current evidence |
| Q52125875 | Two-drug combinations of memory enhancers: Effect of dose ratio upon potency and therapeutic window, in mice |
| Q45130083 | Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock |
| Q52123199 | Vasopressin modulates the activity of nicotinic cholinergic mechanisms during memory retrieval in mice. |
| Q48662653 | Vesicular acetylcholine transporter density and Alzheimer's disease |
Search more.